Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul-Henri Wicky

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Infectious Diseases|January 19, 2022
How common is ventilator-associated pneumonia after coronavirus disease 2019?Paul-Henri Wicky, Camille d'Humières, Jean-François Timsit
Critical Care (London, England)|April 22, 2021
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?Paul-Henri Wicky, Michael S Niedermann, Jean-François Timsit
Antibiotics (Basel, Switzerland)|February 25, 2022
Treatment of Severe Infections Due to Metallo-Betalactamases <i>Enterobacterales</i> in Critically Ill PatientsJean-François Timsit, Paul-Henri Wicky, Etienne de Montmollin
Seminars in Respiratory and Critical Care Medicine|January 18, 2022
HAP and VAP after GuidelinesPaul-Henri Wicky, Ignacio Martin-Loeches, Jean-François Timsit
Intensive Care Medicine|July 5, 2020
Uncharted territories: assessing cerebral vascularization in patients undergoing venoarterial extra-corporeal membrane oxygenationPaul-Henri Wicky, Marie-Cécile Henry-Feugeas, Marylou Para, et al.
Critical Care (London, England)|April 29, 2026
Enhancing humanized care in French ICUs: the potential benefit of welcoming pet visitorsPaul-Henri Wicky, Émilie Marty Petit, Fabienne Bordet, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDSEtienne de Montmollin, Katell Peoc'h, Mehdi Marzouk, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 10, 2025
Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysisCharlotte Rabault, Sébastien Bailly, Michael Thy, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature ReviewPaul-Henri Wicky, Joséphine Poiraud, Manuel Alves, et al.
Critical Care Explorations|November 9, 2022
A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICUSonia Abid, Gregory Papin, Geoffroy Vellieux, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Infectious Diseases|January 19, 2022
How common is ventilator-associated pneumonia after coronavirus disease 2019?Paul-Henri Wicky, Camille d'Humières, Jean-François Timsit
Critical Care (London, England)|April 22, 2021
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?Paul-Henri Wicky, Michael S Niedermann, Jean-François Timsit
Antibiotics (Basel, Switzerland)|February 25, 2022
Treatment of Severe Infections Due to Metallo-Betalactamases <i>Enterobacterales</i> in Critically Ill PatientsJean-François Timsit, Paul-Henri Wicky, Etienne de Montmollin
Seminars in Respiratory and Critical Care Medicine|January 18, 2022
HAP and VAP after GuidelinesPaul-Henri Wicky, Ignacio Martin-Loeches, Jean-François Timsit
Intensive Care Medicine|July 5, 2020
Uncharted territories: assessing cerebral vascularization in patients undergoing venoarterial extra-corporeal membrane oxygenationPaul-Henri Wicky, Marie-Cécile Henry-Feugeas, Marylou Para, et al.
Critical Care (London, England)|April 29, 2026
Enhancing humanized care in French ICUs: the potential benefit of welcoming pet visitorsPaul-Henri Wicky, Émilie Marty Petit, Fabienne Bordet, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDSEtienne de Montmollin, Katell Peoc'h, Mehdi Marzouk, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 10, 2025
Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysisCharlotte Rabault, Sébastien Bailly, Michael Thy, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature ReviewPaul-Henri Wicky, Joséphine Poiraud, Manuel Alves, et al.
Critical Care Explorations|November 9, 2022
A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICUSonia Abid, Gregory Papin, Geoffroy Vellieux, et al.
Pageof 3